RXRX
Price:
$5.92
Market Cap:
$1.63B
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; ...[Read more]
Industry
Biotechnology
IPO Date
2021-04-16
Stock Exchange
NASDAQ
Ticker
RXRX
According to Recursion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.07. This represents a change of 22.71% compared to the average of 4.95 of the last 4 quarters.
The mean historical Current Ratio of Recursion Pharmaceuticals, Inc. over the last ten years is 8.99. The current 6.07 Current Ratio has changed 6.65% with respect to the historical average. Over the past ten years (40 quarters), RXRX's Current Ratio was at its highest in in the June 2021 quarter at 21.92. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
8.99
Median
11.43
Minimum
4.70
Maximum
11.67
Discovering the peaks and valleys of Recursion Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.07%
Maximum Annual Current Ratio = 11.67
Minimum Annual Increase = -50.41%
Minimum Annual Current Ratio = 4.70
Year | Current Ratio | Change |
---|---|---|
2023 | 4.70 | -17.25% |
2022 | 5.68 | -50.41% |
2021 | 11.46 | -1.76% |
2020 | 11.67 | 2.07% |
The current Current Ratio of Recursion Pharmaceuticals, Inc. (RXRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.28
5-year avg
8.99
10-year avg
8.99
Recursion Pharmaceuticals, Inc.’s Current Ratio is less than Absci Corporation (6.49), greater than Affimed N.V. (2.71), greater than Sana Biotechnology, Inc. (5.20), less than Relay Therapeutics, Inc. (15.64), less than Immix Biopharma, Inc. (7.00), greater than CNS Pharmaceuticals, Inc. (0.31), greater than Hepion Pharmaceuticals, Inc. (5.62), greater than Freeline Therapeutics Holdings plc (1.95), less than AVROBIO, Inc. (26.17), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Enveric Biosciences, Inc. (7.37), greater than CohBar, Inc. (4.16), greater than Ocean Biomedical, Inc. (0.03), greater than Day One Biopharmaceuticals, Inc. (4.09), less than Acumen Pharmaceuticals, Inc. (17.37), less than X4 Pharmaceuticals, Inc. (6.07), less than Inozyme Pharma, Inc. (9.84), less than VectivBio Holding AG (9.14),
Company | Current Ratio | Market cap |
---|---|---|
6.49 | $456.50M | |
2.71 | $57.26M | |
5.20 | $1.12B | |
15.64 | $835.47M | |
7.00 | $54.08M | |
0.31 | $4.60M | |
5.62 | $4.20M | |
1.95 | $28.28M | |
26.17 | $5.24M | |
1.03 | $188.18K | |
7.37 | $4.53M | |
4.16 | $1.25M | |
0.03 | $33.96M | |
4.09 | $1.25B | |
17.37 | $133.38M | |
6.07 | $109.78M | |
9.84 | $312.42M | |
9.14 | $1.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recursion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Recursion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Recursion Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Recursion Pharmaceuticals, Inc. (RXRX)?
What is the highest Current Ratio for Recursion Pharmaceuticals, Inc. (RXRX)?
What is the 3-year average Current Ratio for Recursion Pharmaceuticals, Inc. (RXRX)?
What is the 5-year average Current Ratio for Recursion Pharmaceuticals, Inc. (RXRX)?
How does the current Current Ratio for Recursion Pharmaceuticals, Inc. (RXRX) compare to its historical average?